Reperfused gut elaborates paf that chemoattracts and primes neutrophils

Journal of Surgical Research

Volumn 58, Issue 6, 1995, Pages 636-640

  Kim, Fernando J ^a   Moore, Ernest F ^a   Moore, Frederick A ^a   Bifel, Walter L ^a   Fontes, Belchor ^a   Banerjee, Anirban ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEPAFANT; CYTOCHROME C; FORMYLMETHIONYLLEUCYLPHENYLALANINE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE ISCHEMIA; LAPAROTOMY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMAL; CHEMOTAXIS, LEUKOCYTE; INTESTINES; MALE; NEUTROPHILS; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; SUPEROXIDES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029015385     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1006/jsre.1995.1100     Document Type: Article

References (32)

1. Botha, A. J., Moore, F. A., Moore, E. E., Fontes, B., Banerjee, A., and Peterson, V. M. Postinjury neutrophil priming and activation states—Therapeutic challenges. Shock, in press.
2. Carlos, T. M., and Harlan, J. M. Leukocyte-endothelial adhesion molecules. Blood 84: 2068, 1994.
3. Granger, D. N., and Kubes, P. The microcirculation and inflammation-Modulation of leukocyte-endothelial cell adhesion. J. Leukoc. Biol. 55: 662, 1994.
4. Franciose, R. J., Moore, E. E., Moore, F. A., Koike, K., Carl, V. S., and Baneijee, A. Postischemic gut is the priming bed for PMNs. Surg. Forum 54: 142, 1993.
5. Koike, K., Moore, F. A., Moore, E. E., Poggetti, R. S., Tuder, R. M., and Banerjee, A. Endotoxin after gut ischemia -reperfusion causes irreversible lung injury. J. Surg. Res. 52: 656, 1992.
6. Poggetti, R. S., Moore, F. A., Moore, E. E., Koike, K., and Ban-erjee, A, Simultaneous liver and lung injury following gut ischemia is mediated by xanthine oxidase. J. Trauma 32: 723, 1992.
7. 2 inhibition decouples lung injury from gut ischemia-reperfusion. Surgery 112: 173, 1992.
8. 2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am. J. Physiol. 268: 6397, 1995.
9. 2 regulates critical inflammatory mediators of multiple organ failure. J. Surg. Res. 56:199, 1994.
10. Chao, W-, and Olson, M. S. Platelet-activating factor-Receptors and signal transduction. Biochem. J. 292: 617, 1993.
11. Kim, F. J., Moore, E. E., Moore, F. A., Koike, K., Carl, V. S., and Banerjee, A. Disparate signal transduction in neutrophil CD18 adhesion receptor expression versus superoxide generation. Surgery 116: 262, 1994.
12. Koike, K., Moore, E. E., Moore, F. A., Francoise, R. J., Fontes, B., and Kim, F. J. CDllb blockade prevents lung injury despite neutrophil priming following gut ischemia/reperfusion. J. Trauma., in press.
13. Kozel, R. A. Neutrophil recruitment to the gastrointestinal tract. Surg. Res. 53:310, 1992.
14. Vercellotti, G. M., Yin, H. Q., Gustafson, K. S., Nelson, R. D., and Jacob, H. S. Platelet-activating factor primes neutrophil responses to agonists: Role in promoting neutrophil-mediated endothelial damage. Blood 71: 1100, 1988.
15. Heuer, H. O. Current status of PAF antagonists. Clin. Exp. Allergy 22: 980, 1992.
16. Bignold, L. P. Measurement of chemotaxis of polymorphonuclear leukocytes in vitro. J. Immunol. Methods 108: 1, 1988.
17. Tranquillo, R. T., Zigmond, S. H., and Lauffenburger, D. A. Measurement of the chemotaxis coefficient for human neutrophils in the under-agarose migration assay. Cell Motil. Cytoskeleton 11: 1, 1988.
18. Moore, F. A., Moore, E. E., and Read, R. A. Postinjury multiple organ failure: Role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horizons 1: 538, 1993.
19. Hensen, P. M., Barnes, P. J., and Banks-Schlegel, S. P. Platelet activating factor: Role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis. 145: 726, 1992.
20. Whatley, R. E., Zimmerman, G. A., McIntyre, T. M., and Prescott, S. M. Endothelium from diverse vascular sources synthesizes platelet-activating factor. Arteriosclerosis 8: 321, 1994.
21. Mozes, T., Braquet, P., and Filep, J. Platelet-activating factor: An endogenous mediator of mesenteric ischemia-reperfusion -induced shock. Am. J. Physiol. 257: R872, 1989.
22. 2 inhibition prevents mucosal damage associated with small intestinal ischemia in rats. Gut 29:489, 1988.
23. Wallace, J. L., and Whittle, B. J. Profile of gastrointestinal damage induced by platelet activating factor. Prostaglandins 32:137, 1986.
24. Agrawal, D. K., Ali, N., and Numao, T. PAF receptors and G-proteins in human blood eosinophils and neutrophils. J. Lipid Med. 5: 101, 1992.
25. Gay, J. C. Mechanism and regulation of neutrophil priming by platelet-activating factor. J. Cell. Physiol. 156: 189, 1993.
26. Hwang, S. B. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J. Lipid Med. 2: 123, 1990.
27. 2 generation, respectively. J. Clin. Invest. 85:1150, 1990.
28. Arnould, T., Michiels, C., and Remade, J. Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/CDllb, and ICAM-I. Am. J. Physiol. 33: C1102, 1993.
29. Yoshida, N., Granger, D. N., Anderson, D. C., Rothlein, R., Lane, C., and Kvietys, P. R. Am. J. Physiol. 31: H1891, 1992.
30. Zimmerman, G. A., McIntyre, T. M., Mehra, M., and Prescott, S. M. Endothelial cell-associated platelet-activating factor: A novel mechanism for signaling intercellular adhesion, J. Cell Biol. 110:529, 1990.
31. Caterina, M. J., and Devreotes, P. N. Molecular insights into eukaryotic chemotaxis. FASEBJ. 5: 3078, 1991.
32. Norgauer, J., Kownatzki, E., Seifert, R., and Aktories, K. Botulinum C2 toxin ADP-ribosylates actin and enhances 0 production and secretion but inhibits migration of activated human neutrophils. J. Clin. Invest. 82: 1376, 1988.